214 related articles for article (PubMed ID: 16570909)
1. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
3. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
[TBL] [Abstract][Full Text] [Related]
4. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
5. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for high-affinity peptide inhibition of human Pin1.
Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
[TBL] [Abstract][Full Text] [Related]
8. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
[TBL] [Abstract][Full Text] [Related]
9. Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase Pin1.
Ohashi T; Teshima S; Hidaka M; Uchida T
Biosci Biotechnol Biochem; 2010; 74(10):2067-70. PubMed ID: 20944414
[TBL] [Abstract][Full Text] [Related]
10. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
Velazquez HA; Hamelberg D
J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
[TBL] [Abstract][Full Text] [Related]
11. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
Wildemann D; Hernandez Alvarez B; Stoller G; Zhou XZ; Lu KP; Erdmann F; Ferrari D; Fischer G
Biol Chem; 2007 Oct; 388(10):1103-11. PubMed ID: 17937625
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1.
Barman A; Hamelberg D
Biochemistry; 2014 Jun; 53(23):3839-50. PubMed ID: 24840168
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1.
Lippens G; Landrieu I; Smet C
FEBS J; 2007 Oct; 274(20):5211-22. PubMed ID: 17892493
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
[TBL] [Abstract][Full Text] [Related]
15. Aluminum(III) interferes with the structure and the activity of the peptidyl-prolyl cis-trans isomerase (Pin1): a new mechanism contributing to the pathogenesis of Alzheimer's disease and cancers?
Wang JZ; Liu J; Lin T; Han YG; Luo Y; Xi L; Du LF
J Inorg Biochem; 2013 Sep; 126():111-7. PubMed ID: 23806774
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
17. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau.
Smet C; Sambo AV; Wieruszeski JM; Leroy A; Landrieu I; Buée L; Lippens G
Biochemistry; 2004 Feb; 43(7):2032-40. PubMed ID: 14967043
[TBL] [Abstract][Full Text] [Related]
18. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
19. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
[No Abstract] [Full Text] [Related]
20. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
